Prospera Financial Services Inc Astrazeneca PLC Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Prospera Financial Services Inc holds 103,247 shares of AZN stock, worth $6.92 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

103,247

Previous 94,167 9.64%

Holding current value

$6.92 Million

Previous $7.34 Million 9.55%

% of portfolio

0.21%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$76.67 - $87.62 $696,163 - $795,589	9,080 Added 9.64%	103,247 $8.05 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $2.39 Million - $2.9 Million	35,836 Added 61.44%	94,167 $7.34 Million
Q1 2024 Aug 13, 2024	SELL	$61.03 - $69.57 $1.67 Million - $1.91 Million	-27,416 Reduced 29.11%	66,751 $4.52 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $2.5 Million - $2.8 Million	40,430 Added 225.85%	58,331 $3.93 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $144,680 - $159,962	2,231 Added 14.24%	17,901 $1.21 Million
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $5.89 Million - $6.39 Million	-84,316 Reduced 84.33%	15,670 $1.12 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $197,912 - $224,394	-3,134 Reduced 3.04%	99,986 $6.94 Million
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $2.12 Million - $2.75 Million	-39,015 Reduced 27.45%	103,120 $6.99 Million
Q3 2022 Oct 27, 2022	BUY	$53.02 - $135.75 $167,384 - $428,562	3,157 Added 2.27%	142,135 $7.8 Million
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $2.08 Million - $2.5 Million	35,086 Added 33.77%	138,978 $9.18 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $5.34 Million - $6.43 Million	95,776 Added 1180.09%	103,892 $6.89 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $162,222 - $191,681	-3,003 Reduced 27.01%	8,116 $473,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $228,518 - $250,029	4,113 Added 58.71%	11,119 $668,000
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $4,793 - $5,957	-99 Reduced 1.39%	7,006 $420,000
Q1 2021 May 06, 2021	SELL	$47.16 - $54.44 $22,448 - $25,913	-476 Reduced 6.28%	7,105 $354,000
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $244,395 - $292,246	5,037 Added 198.0%	7,581 $378,000
Q3 2020 Nov 04, 2020	SELL	$53.07 - $61.1 $231,225 - $266,212	-4,357 Reduced 63.14%	2,544 $139,000
Q2 2020 Aug 07, 2020	BUY	$43.1 - $55.31 $4,568 - $5,862	106 Added 1.56%	6,901 $365,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $1,322 - $1,796	-35 Reduced 0.51%	6,795 $303,000
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $509 - $605	-12 Reduced 0.18%	6,830 $341,000
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $24,994 - $28,327	623 Added 10.02%	6,842 $305,000
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $231,844 - $259,207	6,219 New	6,219 $256,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $250,670 - $280,256	-6,724 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$35.49 - $43.02 $238,634 - $289,266	6,724 New	6,724 $275,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Astrazeneca PLC Transaction History